California Invests Nearly $30 Million to Advance Cannabis Science, Public Health, and Policy

The California Department of Cannabis Control (DCC) has awarded nearly $30 million in competitive academic research grants to nine public universities, funding 22 new cannabis research projects across the state. Announced in late December 2025, this third cycle of funding brings California’s total investment in cannabis research to nearly $80 million since 2020, reinforcing the state’s commitment to evidence-based policy, public health, and consumer safety.

Funded through cannabis tax revenues established by Proposition 64, the landmark 2016 initiative that legalized adult-use cannabis and began addressing the harms of prohibition, the Cannabis Academic Research Grant Program supports independent, peer-reviewed research examining cannabis through multiple lenses. This year’s awards focus on product safety, youth prevention, aging populations, environmental sustainability, labor protections, illicit markets, and emerging cannabinoid science.

Importantly, all findings will be made publicly available at no cost, expanding access to science-backed information for policymakers, healthcare providers, patients, advocates, and industry stakeholders. In an era of rapid market innovation and evolving regulations, transparency and credible research are critical.

Research in a Rapidly Changing Policy Landscape

While most U.S. states now permit medical cannabis and more than two dozen allow adult use, cannabis remains federally classified as a Schedule I substance under the Controlled Substances Act. This classification has historically limited research opportunities and created major knowledge gaps around safety, efficacy, and long-term impacts.

As federal officials consider rescheduling cannabis, California’s investments position the state as a national leader in filling these gaps. The DCC received 149 proposals during the 2025 funding cycle, selecting projects based on scientific rigor, feasibility, and their ability to inform public policy.

Spotlight on Product Safety, Terpenes, and Cannabinoid Science

A significant portion of this year’s funding centers on product formulation, labeling accuracy, and consumer health.

At University of California, San Francisco, researchers will conduct a major study on the clinical pharmacology of commercially available THC-infused beverages, one of the fastest-growing segments of the cannabis market. By examining THC absorption, onset, and duration across multiple beverage formulations under real-world conditions, the study aims to guide product standards, improve labeling, and reduce unintended overconsumption and impairment risks.

Another UCSF project will investigate how specific cannabinoids affect the brain, including impacts on development, neuroinflammation, and therapeutic pathways. The findings could help define safe dosage thresholds and advance cannabinoid-based medicine while protecting vulnerable populations.

At University of California, Los Angeles, several projects highlight the growing importance of terpene science and next-generation therapeutics. One study will characterize novel cannabinoids with therapeutic potential, supporting safer and more targeted treatment approaches.

A second UCLA-led effort will focus on naturally occurring organoleptic compounds—particularly terpenes—in inhalable cannabis. Researchers will create a Flower Flavor-Compound Reference Dataset to define natural terpene ranges and distinguish authentic plant flavors from prohibited additives. This work supports regulatory enforcement, consumer transparency, and inhalation safety as concerns grow about synthetic flavoring agents.

UCLA Researchers Examine Health Effects and Consumer Risks

The UCLA Center for Cannabis and Cannabinoids, located at the UCLA Semel Institute for Neuroscience and Human Behavior, is playing a central role in advancing cannabis science. According to researchers involved, four state-funded projects totaling approximately $7.3 million will help develop the scientific evidence needed to guide cannabis availability, accessibility, and safety.

Dr. Ziva Cooper, director of the center, is involved in multiple studies examining both cardiovascular effects and flavor additives. While it is known that THC increases heart rate, she notes that the long-term cardiovascular impacts of cannabis remain unclear.

These projects will also explore how modified terpenes and added flavor compounds influence human biology. As cannabis products evolve faster than research can keep pace, Cooper emphasized the need for science-driven policy and consumer education.

Cardiologist Holly Middlekauff added that many patients ask about the safety of smoking or consuming cannabis, but clinicians currently lack strong evidence-based guidance. These studies aim to provide that data.

Other UCLA-led research will examine illicit markets and product safety. Public health researcher Chelsea Shover is studying unregulated cannabis, particularly the risks associated with contaminated vape products. Because illegal products bypass quality testing, consumers often cannot distinguish between regulated and unregulated sources.

Her work seeks to translate complex research into actionable insights for policymakers. Although fatal overdose is extremely rare, excessive use can lead to adverse outcomes including psychosis and cannabis hyperemesis syndrome.

Researchers including Rosalie Liccardo Pacula are also studying whether stricter regulations unintentionally sustain illicit markets by raising legal costs.

Meanwhile, chemist Neil Garg is developing safety testing frameworks for emerging and synthetic cannabinoid products, creating roadmaps that could help ensure safer innovation across the industry.

Broader Impacts: Youth, Workers, Environment, and Equity

Beyond product science, the 2025 awards address some of legalization’s most pressing challenges. Funded studies explore youth prevention strategies, marketing impacts, occupational exposures among cannabis workers, and environmental sustainability in cultivation.

Other projects examine aging populations and cannabis use, retail training, taxation strategies, and partnerships with tribal cannabis markets. These initiatives aim to improve economic equity, protect vulnerable communities, and strengthen regulatory systems.

Science in Service of Sensible Cannabis Policy

Since its formation, the Department of Cannabis Control has prioritized integrity, fairness, innovation, and collaboration in building a sustainable and equitable cannabis industry. The Cannabis Academic Research Grant Program reflects that mission by grounding policy decisions in credible science rather than outdated stigma or speculation.

As data from these projects emerges in the coming years, California will continue to set the global standard for responsible cannabis regulation. At a moment when federal policy may be poised for change, these investments ensure public health, safety, and equity remain at the center of cannabis reform.

For a full list of awardees and research summaries, visit the Department of Cannabis Control’s Cannabis Academic Research Grants webpage.

Follow on social media: @terpeneflashcards @tonybowles420